Half Year 2023 Herantis Pharma Oyj Earnings Call Transcript
This meeting is being recorded.
This is Gabriela Urquilla, Investor Relations for Herantis and I will be the moderator for today's call. Please note this call is being recorded. And for the duration of the call, your lines will be on listen-only.
On the call today, we have Herantis Pharma's CEO Antti Vuolanto; and CFO Tone Kvåle, who will go over the first half report of 2023. At the end of management's remarks, a Q&A session will begin. (Event Instructions)
Additionally, during today's webinar, management may make forward-looking statements that involve known and unknown risks, uncertainties, and other important factors beyond the company's control that could cause the company's actual results, performance, or achievements to be materially different from the expected results and performance and achievements expressed or implied by such forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contained in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
